This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Friedman, E. Articles by Newmark, H. Search for Related Content PubMed PubMed Citation Articles by Friedman, E. Articles by Newmark, H.

Fecal Diglycerides as Selective Endogenous Mitogens for Premalignant and Malignant Human Colonic Epithelial Cells¹

Laboratory of Gastrointestinal Cancer Research and Gastroenterology Service, Memorial Sloan-Kettering Cancer Center, New York, New York 10021 [E. F., B. M., S. W. H. N.]; and the Department of Medical Nutrition, Karolinska Institute, Huddinge University Hospital F69 S-14186 Huddinge, Sweden [P. I., J. R.]

Diglycerides (DGs) have been found in fecal extracts at concentrations which induce mitogenesis of adenoma and some carcinoma cells but not normal cells in primary culture. DGs containing stearic, oleic, palmitic, and myristic acid side chains were found in fecal extracts from each of eight subjects. Synthetic 1,2-DGs, containing the fatty acids found in endogenous fecal DGs, induced mitogenesis in cultures of premalignant cells from each of 13 adenomas, covering all histological classes, and in cultures from two of four carcinomas. The potent adenoma mitogen, dimyristin, had no mitogenic activity on cultures of normal colonic epithelial cells from seven different subjects. These results suggest DGs may act as endogenous mitogens in the development of human colon cancer. The extent of adenoma mitogenesis was correlated with the chain length of the saturated R-groups: 16 > 14 > 12 > 10 > 8 >>> 18. DGs with oleic acid residues, C_18:1, were among the most active, while substitution of even one fatty acid residue with a stearic acid residue, C_18:0, reduced or eliminated mitogenic activity. Dimyristin also induced enhanced levels of urokinase secretion from carcinoma cells, in parallel to the phorbol ester tumor promoter, 12-O-tetradecanoylphorbol-13-acetate. These results imply that DGs found in the colon induce a selective growth of benign colonic tumors and some carcinomas, and may enhance the invasive capacity of carcinomas, while leaving normal cells unaffected.

¹ Supported by American Cancer Society Grant BS-613 to E. A. F. and the Swedish Cancer Society, King Gustaf V Jubilee Fund and ARLA, Stockholm (J. R.).

² To whom requests for reprints should be addressed, at Memorial Sloan-Kettering Cancer Center, P. O. Box 5614, 1275 York Avenue, New York, NY 10021.

Received 7/19/88. Revised 10/ 3/88. Accepted 10/24/88.

This article has been cited by other articles:

				J. Vulevic, A. L. McCartney, J. M. Gee, I. T. Johnson, and G. R. Gibson Microbial Species Involved in Production of 1,2-sn-Diacylglycerol and Effects of Phosphatidylcholine on Human Fecal Microbiota Appl. Envir. Microbiol., September 1, 2004; 70(9): 5659 - 5666. [Abstract] [Full Text] [PDF]

				M Fabre and A Garcia de Herreros Phorbol ester-induced scattering of HT-29 human intestinal cancer cells is associated with down-modulation of E-cadherin J. Cell Sci., January 10, 1993; 106(2): 513 - 521. [Abstract] [PDF]

				A. DeLa Herreros, M Fabre, E Batlle, C Balague, and F. Real The tumor promoter 12-O-tetradecanoylphorbol-13-acetate blocks differentiation of HT-29 human colon cancer cells J. Cell Sci., January 8, 1993; 105(4): 1165 - 1172. [Abstract] [PDF]